Skip to content

Opening book details…

About this Medicine article

Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777 by Beauparlant, Pierre; Bédard, Dominique; Bernier, Cynthia; Chan, Helen; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Lavoie, Manon; Roulston, Anne; Turcotte, Émilie; Watson, Mark is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Beauparlant, Pierre; Bédard, Dominique; Bernier, Cynthia; Chan, Helen; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Lavoie, Manon; Roulston, Anne; Turcotte, Émilie; Watson, Mark
Publisher
Lippincott Williams and Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 0959-4973)
Published
2009
Language
EN
Field
Medicine (Health Sciences)

More by Beauparlant, Pierre; Bédard, Dominique; Bernier, Cynthia; Chan, Helen; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Lavoie, Manon; Roulston, Anne; Turcotte, Émilie; Watson, Mark

Browse all works by Beauparlant, Pierre; Bédard, Dominique; Bernier, Cynthia; Chan, Helen; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Lavoie, Manon; Roulston, Anne; Turcotte, Émilie; Watson, Mark